美国心血管健康补充剂市场：市场规模、份额、趋势分析（按成分、形式、类型、分销管道和地区）、细分市场预测（2025-2030 年）

美国心血管健康补充品市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，美国心血管健康补充品市场规模预计到2030年将达到32.7亿美元，预测期内的复合年增长率为7.61%。

这一强劲增长主要源于心血管疾病患病率的上升、健康意识的增强以及人口老化带来的预防性医疗保健需求的增加。由于心臟相关疾病仍然是美国最大的死亡原因，消费者正在转向天然的非处方笺解决方案来管理和降低相关风险。

Omega-3脂肪酸、辅酶Q10、镁和植物固醇等关键成分因其在支持心臟健康方面的功效已被证实，继续占据市场主导地位。此外，软胶囊、胶囊和缓释片等补充剂输送系统的进步正在提高生物利用度和消费者依从性。向洁净标示、植物来源和临床支持配方的转变也影响着消费者的购买决策，尤其是在註重健康的老年人群中，他们寻求长期健康解决方案。这将在预测期内推动美国对心血管健康补充剂的需求。

新冠疫情显着提升了美国市场对心血管健康补充剂的需求，这得益于人们健康意识的增强、对免疫力和慢性病预防的日益关注，以及人们更加註重积极健康的生活方式。消费者对自身基础健康（包括心臟健康）的关注度不断提升，导致对含有Omega-3、辅酶 Q10 和其他有益心臟成分的补充剂的需求激增。

然而，儘管需求不断增长，美国心血管健康补充剂产业仍面临许多挑战，包括有限的临床检验、有关健康声明的限制性法规以及各品牌产品品质缺乏一致性。这些因素加剧了消费者的疑虑，并降低了医疗保健专业人员的采用率。此外，高昂的产品成本和缺乏保险覆盖进一步限制了产品的可及性，共同阻碍了市场的成长。

美国心血管健康补充品市场：分析概述

• 2024年，欧米伽脂肪酸占据了最大的市场占有率，达到27.36%，这得益于其在降低高胆固醇和高血压等心血管风险因素方面众所周知的作用。然而，预计在预测期内，草药和植物药的复合年增长率将最快。
• 预计天然补充剂领域将在 2024 年占据市场主导地位，并在预测期内以最快的复合年增长率增长，这归因于消费者对洁净标示、植物来源、最低限度加工且具有公认安全性和长期健康益处的产品的偏好日益增长。
• 软胶囊凭藉其便捷的剂型和消费者对易于服用的补充剂的偏好，在2024年占据了最大的市场占有率。然而，预计在预测期内，胶囊的复合年增长率将达到最高。
• 线下分销管道部分将在 2024 年占据市场主导地位，占据最大的收益占有率。然而，预计在预测期内，线上部分将以最快的复合年增长率成长。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 市场驱动因素、趋势与范围

• 市场联动展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制分析
• 美国心血管健康补充品市场：分析工具
  • 产业分析：波特五力分析
  • PESTEL分析
  • COVID-19影响分析

第四章美国心血管健康补充剂市场：按成分的估计和趋势分析

• 特定成分的仪表板
• 美国心血管保健品市场成分波动
• 美国心血管健康补充品市场规模及成分趋势分析（2018-2030）
• 维生素和矿物质
  • 维生素和矿物质市场（2018-2030）
• 草药和植物
  • 草药和植物市场（2018-2030）
• 欧米茄脂肪酸
  • 欧米茄脂肪酸市场（2018-2030）
• Coenzyme Q10（CoQ10）
  • Coenzyme Q10（CoQ10）市场（2018-2030）
• 其他的
  • 其他市场（2018-2030）

第五章美国心血管健康补充剂市场：按类型估计和趋势分析

• 按类型分類的仪表板
• 美国心血管保健品市场各类型波动
• 美国心血管健康补充品市场规模及趋势分析（2018-2030）
• 天然补充品
  • 天然补充品市场（2018-2030）
• 合成补充剂
  • 合成补充剂市场（2018-2030）

第六章美国心血管健康补充剂市场：按形式进行的估计和趋势分析

• 按形状分类的仪表板
• 美国心血管保健品市场各形态的波动
• 美国心血管健康补充品市场规模及趋势分析（2018-2030）
• 液体
  • 流动性市场（2018-2030）
• 锭剂
  • 锭剂市场（2018-2030）
• 胶囊
  • 胶囊市场（2018-2030）
• 软胶囊
  • 软胶囊市场（2018-2030）
• 粉末
  • 粉末市场（2018-2030）
• 其他的
  • 其他市场（2018-2030）

第七章美国心血管健康补充品市场：通路评估与趋势分析

• 按分销管道分類的仪表板
• 美国心血管保健品市场通路的波动
• 美国心血管健康补充品市场规模及通路趋势分析（2018-2030）
• 离线
  • 线下市场（2018-2030）
• 在线的
  • 线上市场（2018-2030）

第八章 竞争态势

• 公司分类
• 战略地图
• 公司简介/上市公司
  • NOW Foods
  • Bright Lifecare Private Ltd（Truebasics.com）
  • Natural Organics, Inc.
  • DaVinci Laboratories of Vermont
  • Nordic Naturals
  • Thorne.
  • Nestle Health Science（Pure Encapsulations, LLC.）
  • Amway Corp.
  • InVite Health
  • GNC Holdings, LLC

U.S. Cardiovascular Health Supplements Market Growth & Trends:

The U.S. cardiovascular health supplements market size is anticipated to reach USD 3.27 billion by 2030 and is projected to grow at a CAGR of 7.61% during the forecast period, according to a new report by Grand View Research, Inc. This robust growth is largely attributed to the increasing incidence of cardiovascular diseases, rising health consciousness, and the aging population's growing demand for preventive healthcare. As heart-related conditions remain a leading cause of mortality in the U.S., consumers are increasingly seeking non-prescription, natural solutions to manage and reduce associated risks.

Key ingredients such as omega-3 fatty acids, CoQ10, magnesium, and plant sterols continue to dominate the market due to their proven benefits in supporting heart health. In addition, advancements in supplement delivery systems-such as softgels, capsules, and extended-release tablets-are enhancing bioavailability and consumer adherence. The shift toward clean-label, plant-based, and clinically supported formulations is also influencing purchasing decisions, especially among health-conscious and senior demographics seeking long-term wellness solutions. Thereby propelling the demand for cardiovascular health supplements in the U.S. over the forecast period.

The COVID-19 pandemic substantially boosted the demand for cardiovascular health supplements in the U.S. market, driven by heightened health awareness, increased focus on immunity and chronic disease prevention, and a shift toward proactive wellness. Consumers became more conscious of underlying health conditions, including heart health, leading to a surge in demand for supplements containing omega-3s, CoQ10, and other heart-supportive ingredients.

However, despite rising demand, the U.S. cardiovascular health supplements industry faces challenges such as limited clinical validation, regulatory restrictions on health claims, and inconsistent product quality across brands. These factors contribute to consumer skepticism and reduce adoption among healthcare professionals. In addition, high product costs and lack of insurance coverage further limit accessibility, collectively hampering the growth of the market.

U.S. Cardiovascular Health Supplements Market Report Highlights:

• The omega fatty acids held the largest market share of 27.36% in 2024. This is attributed to their well-documented benefits in reducing cardiovascular risk factors such as high cholesterol and blood pressure. However, herbs & botanicals are anticipated to grow at the fastest CAGR over the forecast period.
• The natural supplements segment dominated the market in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by increasing consumer preference for clean-label, plant-based, and minimally processed products with perceived safety and long-term health benefits.
• The softgels held the largest market share in 2024. This is driven by their convenient dosage form and consumer preference for easy-to-consume supplements. However, capsules are anticipated to grow at the fastest CAGR over the forecast period.
• The offline distribution channel segment dominated the market with the largest revenue share in 2024. However, the online segment is expected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Ingredient Segment
  • 1.2.2. Type Segment
  • 1.2.3. Form Segment
  • 1.2.4. Distribution Channel Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of cardiovascular diseases
    • 3.2.1.2. Aging population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High competition and market saturation
• 3.3. U.S. Cardiovascular Health Supplements Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Cardiovascular Health Supplement Market: Ingredient Estimates & Trend Analysis

• 4.1. Ingredient Segment Dashboard
• 4.2. U.S. Cardiovascular Health Supplement Market Ingredient Movement Analysis
• 4.3. U.S. Cardiovascular Health Supplement Market Size & Trend Analysis, by Ingredient, 2018 to 2030 (USD Million)
• 4.4. Vitamins & Minerals
  • 4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
• 4.5. Herbs & Botanicals
  • 4.5.1. Herbs & Botanicals Market, 2018 - 2030 (USD Million)
• 4.6. Omega Fatty Acids
  • 4.6.1. Omega Fatty Acids Market, 2018 - 2030 (USD Million)
• 4.7. Coenzyme Q10 (CoQ10)
  • 4.7.1. Coenzyme Q10 (CoQ10) Market, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Cardiovascular Health Supplement Market: Type Estimates & Trend Analysis

• 5.1. Type Segment Dashboard
• 5.2. U.S. Cardiovascular Health Supplement Market Type Movement Analysis
• 5.3. U.S. Cardiovascular Health Supplement Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Natural Supplements
  • 5.4.1. Natural Supplements Market, 2018 - 2030 (USD Million)
• 5.5. Synthetic Supplements
  • 5.5.1. Synthetic Supplements Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Cardiovascular Health Supplements Market: Form Estimates & Trend Analysis

• 6.1. Form Segment Dashboard
• 6.2. U.S. Cardiovascular Health Supplements Market Form Movement Analysis
• 6.3. U.S. Cardiovascular Health Supplements Market Size & Trend Analysis, by Form, 2018 to 2030 (USD Million)
• 6.4. Liquid
  • 6.4.1. Liquid Market, 2018 - 2030 (USD Million)
• 6.5. Tablet
  • 6.5.1. Tablet Market, 2018 - 2030 (USD Million)
• 6.6. Capsules
  • 6.6.1. Capsules Market, 2018 - 2030 (USD Million)
• 6.7. Softgels
  • 6.7.1. Softgels Market, 2018 - 2030 (USD Million)
• 6.8. Powder
  • 6.8.1. Powder Market, 2018 - 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Cardiovascular Health Supplements Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Distribution Channel Segment Dashboard
• 7.2. U.S. Cardiovascular Health Supplements Market Distribution Channel Movement Analysis
• 7.3. U.S. Cardiovascular Health Supplements Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 7.4. Offline
  • 7.4.1. Offline Market, 2018 - 2030 (USD Million)
• 7.5. Online
  • 7.5.1. Online Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Profiles/Listing
  • 8.3.1. NOW Foods
    • 8.3.1.1. Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Bright Lifecare Private Ltd (Truebasics.com)
    • 8.3.2.1. Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Natural Organics, Inc.
    • 8.3.3.1. Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. DaVinci Laboratories of Vermont
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Nordic Naturals
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Thorne.
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Nestle Health Science (Pure Encapsulations, LLC.)
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Amway Corp.
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. InVite Health
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. GNC Holdings, LLC
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives

List of Tables

• Table 1. U.S. cardiovascular health supplements market estimates & forecasts
• Table 2. U.S. cardiovascular health supplements market estimates & forecasts, by ingredient, 2018 - 2030 (USD Million)
• Table 3. U.S. cardiovascular health supplements market estimates & forecasts, by type, 2018 - 2030 (USD Million)
• Table 4. U.S. cardiovascular health supplements market estimates & forecasts, by form, 2018 - 2030 (USD Million)
• Table 5. U.S. cardiovascular health supplements market estimates & forecasts, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market snapshot
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market trends & outlook
• Fig. 7 Market segmentation & scope
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 PESTLE Analysis
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Strategy framework
• Fig. 13 Participant categorization
• Fig. 14 U.S. cardiovascular health supplements market: Ingredient outlook key takeaways
• Fig. 15 U.S. cardiovascular health supplements market: Ingredient movement analysis
• Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
• Fig. 17 Herbs & botanicals market, 2018 - 2030 (USD Million)
• Fig. 18 Omega fatty acids market, 2018 - 2030 (USD Million)
• Fig. 19 Coenzyme Q10 (CoQ10) market, 2018 - 2030 (USD Million)
• Fig. 20 Others market, 2018 - 2030 (USD Million)
• Fig. 21 U.S. cardiovascular health supplements market: Type outlook key takeaways
• Fig. 22 U.S. cardiovascular health supplements market: Type movement analysis
• Fig. 23 Natural supplements market, 2018 - 2030 (USD Million)
• Fig. 24 Synthetic supplements market, 2018 - 2030 (USD Million)
• Fig. 25 U.S. cardiovascular health supplements market: Form outlook key takeaways
• Fig. 26 U.S. cardiovascular health supplements market: Form movement analysis
• Fig. 27 Liquid market, 2018 - 2030 (USD Million)
• Fig. 28 Capsules market, 2018 - 2030 (USD Million)
• Fig. 29 Tablets market, 2018 - 2030 (USD Million)
• Fig. 30 Softgels market, 2018 - 2030 (USD Million)
• Fig. 31 Powder market, 2018 - 2030 (USD Million)
• Fig. 32 Others market, 2018 - 2030 (USD Million)
• Fig. 33 U.S. cardiovascular health supplements market: End use outlook key takeaways
• Fig. 34 U.S. cardiovascular health supplements market: End use movement analysis
• Fig. 35 Offline market, 2018 - 2030 (USD Million)
• Fig. 36 Online market, 2018 - 2030 (USD Million)
• Fig. 37 U.S. cardiovascular health supplements market, 2018 - 2030 (USD Million)
• Fig. 38 Key companies profiled